New Yortk, US - September 03, 2026 To accelerate anti-aging research, CD BioSciences announces the release of its full-suite Heterocephalus glaber (NMR) model customization services, supporting academic and industry efforts targeting longevity research and therapeutic development.
Heterocephalus glaber, commonly abbreviated as NMRs, are notable among rodents for their exceptional longevity and unusual aging phenotype. NMRs exhibit unusually slow age-related declines across much of their lifespan, with several physiological and pathological features of aging appearing later than in conventional laboratory rodents. They also exhibit relative resistance to several age-associated pathologies, including cancer and certain forms of tissue and physiological decline. Constant reproductive capacity and age-independent mortality have led some researchers to hypothesize that NMRs may represent a valuable mammalian model for studying negligible senescence and mechanisms of healthy longevity, making them highly valuable as an NMR model for anti-aging drug discovery.
CD BioSciences delivers flexible model customization workflows tailored to diverse experimental requirements. Its expert team can develop dietary intervention models incorporating controlled caloric restriction, nutrient supplementation, and targeted dietary manipulations to probe links between nutrition, metabolism, and lifespan. Researchers can access custom longevity phenotyping in NMRs, covering lifespan monitoring, longitudinal tracking of aging-related biomarkers, and multidimensional physiological assessments. The team will collaborate closely with clients to build and run customized long-term studies, generating robust datasets for aging-focused investigations.
Complementing model generation and phenotyping, CD BioSciences performs a broad panel of physiological and biochemical assays. Measurements include body temperature, metabolic rate, fasting glucose, glucose tolerance test outcomes, insulin levels, thyroid hormone profiles, and body fat percentage, enabling thorough characterization of NMR physiological states.
To decode the molecular foundations of NMR longevity, CD BioSciences also provides multi-layered mechanism analysis services. Genome stability analyses can assess DNA damage and mutation-related changes to investigate mechanisms that may contribute to the maintenance of genomic integrity during aging in NMRs. Protein homeostasis analysis assesses protein folding, aggregate formation and clearance pathways, offering insights into mechanisms involved in resistance to age-associated proteotoxic stress. Tissue integrity analysis evaluates tissue structure and function in aged NMR samples, examining stem cell behavior, cellular senescence and regenerative potential. Collectively, these analyses assist investigators in identifying candidate molecular targets for developing healthy aging interventions.
CD BioSciences' integrated service portfolio enables investigators to leverage the unique biological traits of NMRs to unravel longevity mechanisms and translate findings toward innovative therapeutic strategies. Interested research teams may reach out to CD BioSciences for further consultation or online project inquiries.
About CD BioSciences
CD BioSciences is a specialized provider of customized preclinical animal model development, molecular biology, and translational research services. It specializes in custom aging disease and transgenic model systems across multiple aquatic and mammalian species, supporting target validation, mechanism exploration, and small-molecule therapeutic screening for academic, biotech, and pharmaceutical partners worldwide.
Media Contact
Company Name: CD BioSciences
Contact Person: Kikiwi Davis
Email: Send Email
Country: United States
Website: https://www.agingclocks.com/drug-development/
